Collaborative Activities with Genedata
01.02.2017 | New Genedata Screener® APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017
MUNICH, GERMANY, February 1, 2017 -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced new automated patch clamp (APC) functionality in Genedata Screener for Ion Channel Screening and a Genedata Ready-to-Run integration with Nanion SyncroPatch 384PE. The package provides seamless data capture and innovative analysis of Nanion's multi-sweep, multi-dose current traces as well as interactive access to the raw traces for visualization and analysis optimization. The Genedata Screener/Nanion SyncroPatch 384PE integration will be demonstrated along with the new functionality at an SLAS2017 tutorial session, one of the Genedata Screener events at SLAS2017. Genedata will present at Booth #541; Nanion Technologies will present at Booth #1311 (Walter E. Washington Convention Center, Washington, DC Feb. 4-8.)
Read full press release here.
Conference Venue: Walter E. Washington Convention Center, Washington DC, USA
Go to the Conference website here.
07.06.2016 | External Webinar: A new analysis capability to improve assessment of cardiac liability in high throughput electrophysiology
AstraZeneca has implemented the Nanion SyncroPatch 384PE electrophysiology platform. This webinar will show how AstraZeneca and Genedata developed a processing and analysis pipeline for the complex data, reading binary raw data directly from the instrument into Genedata Screener.
Organisation: Genedata AG.
11.08.2015 | New Genedata Ready-to-Run Delivers Out-of-the-Box Integration with Leading Screening Devices IntelliCyt , Labcyte, Nanion Technologies
MUNICH, GERMANY, August 11 2015 -- "New Genedata Ready-to-Run Delivers Out-of-the-Box Integration with Leading Screening Devices IntelliCyt , Labcyte, Nanion Technologies, and Thermo Scientific sign up as first partners for turnkey instrument integrations that effortlessly enable researchers to plug in new instruments to analysis pipelines.